United Therapeutics Corporation

Stories

Former New Hampshire brewery sold to organ-transplant biotech

As of September 2026: New owner of the former Anheuser-Busch plant in Merrimack

A former Anheuser-Busch brewery in Merrimack, New Hampshire, is becoming an organ-manufacturing site. United Therapeutics, a biotech company that builds 3D-printed organ scaffolds and gene-edited pig organs, paid $47.5 million for the nearly 300-acre property that Anheuser-Busch shut down in December.

Updated Sep 6

FDA approves United Therapeutics LungFX to reassess discarded donor lungs

New Capabilities

As of June 2026: Holder of the LungFX premarket approval

More than 8 in 10 donor lungs recovered from deceased donors never reach a patient. On June 29, 2026, the FDA approved a device built to change that math. United Therapeutics won premarket approval for LungFX, a system that keeps donor lungs warm, ventilated, and pumped with fluid outside the body so transplant teams can re-examine organs they had already rejected.

Updated Jun 29